The role of gender dimorphism in the development and outcome of chronic viral hepatitis

V.B. Yagmur


Chronic viral liver diseases still have a leading place in the structure of mortality from hepatobiliary diseases and causes of liver transplantation. Search for factors influencing the progression of fibrosis and the prognosis of the disease are of public health priority. The article provides an overview of the research on the influence of sex hormones on the progression of liver fibrosis, the likelihood of hepatocellular carcinoma development in men and women of reproductive age and menopausal state.


estradiol; testosterone; chronic viral hepatitis; menopause; review


Villa E, Vukotic R, Camma C, et al. Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C. PLoS ONE. 2012;7(9):e44624.

Wiese M, Grungreiff K, Guthoff W, et al. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany — a 25-year multicenter study. J Hepatol. 2005;43:590-8.

Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002;36:35-46. doi: 10.1053/jhep.2002.36806.

Bissell DM. Sex and hepatic fibrosis. Hepatology. 1999;29:988-989. doi: 10.1002/hep.510290351.

Conte D, Fraquelli M, Prati D, et al. Prevalence and Clinical Course of Chronic Hepatitis C Virus (HCV) Infection and Rate of HCV Vertical Transmission in a Cohort of 15250 Pregnant Women. Hepatology. 2000;31:751-755. doi: 10.1002/hep.510310328.

Ahmed NH, El-Abaseri TB, El-Sayed HF, El-Serafi TI. Female Sex Hormones Pattern and Its Relation to Disease Severity and Treatment in Pre- and Postmenopausal Patients with Chronic Hepatitis C Virus (Genotype 4) Infection. International Journal of Chronic Diseases. 2015;2015:927974. doi: 10.1155/2015/927974. Epub 2015 Aug 17.

Kireev R, Tresguerres A, Garcia C, et al. Hormonal regulation of pro-inflammatory and lipid peroxidation processes in liver of old ovariectomized female rats. Biogerontology. 2010;11(2):229-243. doi: 10.1007/s10522-009-9242-2. Epub 2009 Jul 26.

Lu G, Shimizu I, Cui X, et al. Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats. Life Sciences. 2004;74(7):897-907.

Yuan Y, Shimizu I, Shen M, et al. Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C. World Journal of Gastroenterology. 2008;14(14):2200-2207. doi: 10.3748%2Fwjg.14.2200.

Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat. 2006;13(1):34-41. doi: 10.1111/j.1365-2893.2005.00651.x.

Soriano V, Mocroft A, Rockstroh J, et al. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis. 2008;198:1337-44. doi: 10.1086/592171.

Danta M, Semmo N, Fabris P, et al. Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis. 2008;197(11):1558-66. doi: 10.1086/587843.

Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med. 1999;340:1228-1233. doi: 10.1056/NEJM199904223401602.

Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology. 2000;32:91-96. doi: 10.1053/jhep.2000.8169.

Bakr I, Rekacewicz C, Hosseiny M, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut. 2006;55(8):1183-7. doi:10.1136/gut.2005.078147.

Van den Berg CH, Grady BP, Schinkel J, et al. Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PloS One. 2011;6(11). doi: 10.1371/journal.pone.0027555.

Ikezaki H, Furusyo N, Hiramine S, et al. Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study. Arch Virol. 2016;161(3):641-648. doi: 10.1007/s00705-015-2703-9.

Alter M, Kruszon-Moran D, Nainan O, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-62. doi: 10.1056/NEJM199908193410802.

Mohsen AH, Trent HCV Study Group. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut. 2001;48:707-713. doi: 10.1136%2Fgut.48.5.707.

Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002;36:S21-9. doi: 10.1053/jhep.2002.36227.

Di Martino V, Lebray P, Myers RP, et al. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology. 2004;40(6):1426-33. doi: 10.1002/hep.20463.

Codes L, Asselah T, Cazals-Hatem D, et al. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut. 2007;56:390-395. doi: 10.1136%2Fgut.2006.101931.

Corsi DJ, Karges W, Thavorn K, Crawley AM, Cooper CL. Influence of female sex on hepatitis C virus infection progression and treatment outcomes. Eur J Gastroenterol Hepatol. 2016;28(4):405-411. doi: 10.1097/MEG.0000000000000567.

Maruyama Y, Adachi Y, Aoki N, Suzuki Y, Shinohara H, Yamamoto T. Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: role of sex hormone-binding globulin. Gastroenterologia Japonica. 1991;26(4):435-439.

Mucci LA, Kuper HE, Tamimi R, Laqiou P, Spanos E, Trichopoulos D. Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. BJOG. 2001;108(3):291-4.

Nguyen HV, Mollison LC, Taylor TW, Chubb SA, Yeap BB. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-𝛼 therapy. Internal Medicine Journal. 2006;36(6):362-6. doi: 10.1111/j.1445-5994.2006.01093.x.

Velazquez I, Alter BP. Androgens and liver tumors: Fanconi’s anemia and non-Fanconi’s conditions. American Journal of Hematology. 2004;77(3):257-267. doi: 10.1002/ajh.20183.

Vassilatou E, Lafoyianni S, Vryonidou A, et al. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Human Reproduction. 2010;25(1):212-220. doi: 10.1093/humrep/dep380.

London W, Drew J. Sex differences in response to hepatitis B infection among patients receiving chronic dialysis treatment. Proc Natl Acad Sci USA. 1977;74(6):2561-2563.

Tsai JF, Chuang LY, Jeng JE, et al. Sex differences in relation to serum hepatitis Be antigen and alanine aminotransferase levels among asymptomatic hepatitis B surface antigen carriers. J Gastroenterol. 2000;35(9):690-695.

Stroffolini N, Esvan R, Biliotti E, Sagnelli E, Gaeta GB, Almasio PL. Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease. J Med Virol. 2015;87(11):1899-903. doi: 10.1002/jmv.24243. Epub 2015 Jun 2.

Tanaka K, Sakai H, Hashizume M, Hirohata T. Serum testosterone: estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Research. 2000;60(18):5106-10.

Niu JJ, Su YH, Han YF, et al. Synergistic effects of different types of smoking and other risk factors on risk of hepatocellular carcinoma in Xiamen, China. Chin J Epidemiol. 2010;31(8):850-855.

Rando G, Wahli W. Sex differences in nuclear receptor-regulated liver metabolic pathways. Biochimica et Biophysica Acta. 2011;1812:964-973. doi: 10.1016/j.bbadis.2010.12.023.

Copyright (c) 2017 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2019


   Seo анализ сайта